Comparing balloon-expandable and self-expanding transfemoral transcatheter aortic valve replacement based on subgroups in Germany 2019/2020
Background Previously, overall comparable outcomes were seen for balloon-expandable (BE) or self-expanding (SE) transfemoral transcatheter aortic valve replacement (TAVR). However, subgroup analyses based on large case numbers are still needed. Methods German national data of all BE and SE transfemoral TAVR treating aortic valve stenosis in 2019 and 2020 were analysed. We then compared different outcomes and performed a subgroup analysis for the endpoint in-hospital mortality. Results Overall, 46,243 TAVR were analysed, 19,910 BE, and 26,333 SE. Patients in the SE group had a significantly higher logistic EuroSCORE (13.61 vs 12.66%, p < 0.001), age (81.55 vs 79.99a, p < 0.001), and proportion of women (54.82 vs 40.06%, p < 0.001). Both groups showed a similar in-hospital mortality with 2.37% in BE and 2.35% in SE (p = 0.916). In-hospital mortality also did not differ significantly after risk adjustment (OR = 0.98 [0.86, 1.13], p = 0.799). Patients in the SE group had a significantly lower risk of major bleeding (OR = 0.83 [0.73, 0.95], p = 0.006), but a significantly higher risk of stroke (OR = 1.38 [1.19, 1.59], p < 0.001), delirium (OR = 1.15 [1.06, 1.24], p = 0.001), and permanent pacemaker implantation (OR = 1.29 [1.21, 1.37], p < 0.001). In the subgroup analysis of in-hospital mortality, there were no significant differences in any of the observed subgroups (age < 75/75–79/80–84/ ≥ 85a, logistic EuroSCORE < 4/4– < 9/ ≥ 9, gender, NYHA III/IV, previous CABG, peripheral vascular disease, COPD, pulmonary hypertension, renal disease GFR < 30 ml/min, and diabetes mellitus). Conclusion In the direct comparison of balloon-expandable and self-expanding TAVR, there are no differences for in-hospital mortality in subgroups. Graphical abstract.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:113 |
|---|---|
| Enthalten in: |
Zeitschrift für Kardiologie - 113(2023), 1 vom: 20. Nov., Seite 168-176 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Oettinger, Vera [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Aortic valve stenosis |
|---|
| Anmerkungen: |
© The Author(s) 2023 |
|---|
| doi: |
10.1007/s00392-023-02326-w |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR054500303 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR054500303 | ||
| 003 | DE-627 | ||
| 005 | 20240125064742.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240125s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00392-023-02326-w |2 doi | |
| 035 | |a (DE-627)SPR054500303 | ||
| 035 | |a (SPR)s00392-023-02326-w-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Oettinger, Vera |e verfasserin |0 (orcid)0000-0003-4460-2102 |4 aut | |
| 245 | 1 | 0 | |a Comparing balloon-expandable and self-expanding transfemoral transcatheter aortic valve replacement based on subgroups in Germany 2019/2020 |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2023 | ||
| 520 | |a Background Previously, overall comparable outcomes were seen for balloon-expandable (BE) or self-expanding (SE) transfemoral transcatheter aortic valve replacement (TAVR). However, subgroup analyses based on large case numbers are still needed. Methods German national data of all BE and SE transfemoral TAVR treating aortic valve stenosis in 2019 and 2020 were analysed. We then compared different outcomes and performed a subgroup analysis for the endpoint in-hospital mortality. Results Overall, 46,243 TAVR were analysed, 19,910 BE, and 26,333 SE. Patients in the SE group had a significantly higher logistic EuroSCORE (13.61 vs 12.66%, p < 0.001), age (81.55 vs 79.99a, p < 0.001), and proportion of women (54.82 vs 40.06%, p < 0.001). Both groups showed a similar in-hospital mortality with 2.37% in BE and 2.35% in SE (p = 0.916). In-hospital mortality also did not differ significantly after risk adjustment (OR = 0.98 [0.86, 1.13], p = 0.799). Patients in the SE group had a significantly lower risk of major bleeding (OR = 0.83 [0.73, 0.95], p = 0.006), but a significantly higher risk of stroke (OR = 1.38 [1.19, 1.59], p < 0.001), delirium (OR = 1.15 [1.06, 1.24], p = 0.001), and permanent pacemaker implantation (OR = 1.29 [1.21, 1.37], p < 0.001). In the subgroup analysis of in-hospital mortality, there were no significant differences in any of the observed subgroups (age < 75/75–79/80–84/ ≥ 85a, logistic EuroSCORE < 4/4– < 9/ ≥ 9, gender, NYHA III/IV, previous CABG, peripheral vascular disease, COPD, pulmonary hypertension, renal disease GFR < 30 ml/min, and diabetes mellitus). Conclusion In the direct comparison of balloon-expandable and self-expanding TAVR, there are no differences for in-hospital mortality in subgroups. Graphical abstract | ||
| 650 | 4 | |a Aortic valve stenosis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Transcatheter aortic valve replacement |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Transcatheter aortic valve implantation |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a In-hospital mortality |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Subgroup analysis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a National electronic health records |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Hilgendorf, Ingo |0 (orcid)0000-0002-0024-1643 |4 aut | |
| 700 | 1 | |a Wolf, Dennis |0 (orcid)0000-0003-1525-4348 |4 aut | |
| 700 | 1 | |a Rilinger, Jonathan |0 (orcid)0000-0001-9333-3629 |4 aut | |
| 700 | 1 | |a Maier, Alexander |0 (orcid)0000-0003-0200-7495 |4 aut | |
| 700 | 1 | |a Zehender, Manfred |4 aut | |
| 700 | 1 | |a Westermann, Dirk |0 (orcid)0000-0002-7542-1956 |4 aut | |
| 700 | 1 | |a Kaier, Klaus |0 (orcid)0000-0003-0837-6945 |4 aut | |
| 700 | 1 | |a von zur Mühlen, Constantin |0 (orcid)0000-0003-2767-8009 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Zeitschrift für Kardiologie |d Darmstadt : Steinkopff, 1997 |g 113(2023), 1 vom: 20. Nov., Seite 168-176 |w (DE-627)SPR004794893 |w (DE-600)1463330-9 |x 1435-1285 |7 nnns |
| 773 | 1 | 8 | |g volume:113 |g year:2023 |g number:1 |g day:20 |g month:11 |g pages:168-176 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00392-023-02326-w |z kostenfrei |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 113 |j 2023 |e 1 |b 20 |c 11 |h 168-176 | ||